image
Healthcare - Biotechnology - NASDAQ - US
$ 0.7851
1.53 %
$ 37.6 M
Market Cap
-0.53
P/E
BALANCE SHEET
91 M ASSETS
-42.94%
11.4 M LIABILITIES
-23.12%
79.6 M EQUITY
-44.97%
BALANCE SHEET DECOMPOSITION
Balance Sheet Shattuck Labs, Inc.
image
Current Assets 79.2 M
Cash & Short-Term Investments 73 M
Receivables 0
Other Current Assets 6.23 M
Non-Current Assets 11.8 M
Long-Term Investments 0
PP&E 9.81 M
Other Non-Current Assets 2.02 M
80.16 %6.84 %10.78 %Total Assets$91.0m
Current Liabilities 8.92 M
Accounts Payable 2.42 M
Short-Term Debt 0
Other Current Liabilities 6.5 M
Non-Current Liabilities 2.51 M
Long-Term Debt 2.51 M
Other Non-Current Liabilities 0
21.18 %56.89 %21.94 %Total Liabilities$11.4m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 57.4 125.6 47.4 92.3 157.9 7.0 31.6
Short Term Investments 15.6 5.0 113.9 176.5 177.6 32.1 28.7
Receivables 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0
Other Current Assets 6.2 12.6 23.3 38.9 20.4 3.4 5.3
Total Current Assets 79.2 143.2 184.6 288.3 345.6 42.4 65.6
PP&E 9.8 13.8 17.7 9.9 3.0 2.4 2.5
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0
Other Long Term Assets 2.0 2.5 3.1 0.4 0.3 90 K 23 K
Other Assets 0 0 0 0 0 0 0
Total Assets 91.0 159.6 205.3 298.6 349.0 45.0 68.2
LIABILITIES
Accounts Payable 2.4 1.6 7.2 10.0 1.8 3.1 2.0
Short Term Debt 0 0.8 0.7 0 0 0 0
Other Current Liabilities 6.5 9.1 17.1 14.6 7.4 4.0 1.8
Total Current Liabilities 8.9 11.5 25.0 24.6 16.8 20.0 20.9
Long Term Debt 2.5 3.4 4.2 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 0 0 0 2.2 1.0 50.0 50.0
Total Liabilities 11.4 14.9 29.2 26.8 39.1 79.5 79.2
EQUITY
Common Stock 5 K 5 K 5 K 5 K 5 K 1 K 1 K
Retained Earnings (381.7) (306.3) (219.0) (117.1) (72.1) (35.5) (11.5)
Other Accumulative Comprehensive Income/Loss 2 K 4 K (0.9) (0.6) 63 K 54 K (49.1)
Total Equity 79.6 144.7 176.2 271.8 309.9 (34.5) (11.1)
Total Liabilities and Equity 91.0 159.6 205.3 298.6 349.0 45.0 68.2
SHARES OUTSTANDING
Common Shares Outstanding 50.8 42.6 42.4 42.0 41.8 41.7 15.0